These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13453098)

  • 41. [Preliminary experiences with re-infusion of ascitic fluid, partially desalinated and concentrated with the artificial kidney].
    Amerio A; Leondeff J; Coratelli P; Mastrangelo F; Chiummo R; Trotta M
    Minerva Med; 1967 Jun; 58(45):2125-30. PubMed ID: 6028374
    [No Abstract]   [Full Text] [Related]  

  • 42. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 43. [Therapy refractory ascites: insertion of a tunneled long-term peritoneal catheter].
    Semmo N; Seuthe B; Thimme R; Graf KJ
    Dtsch Med Wochenschr; 2009 Oct; 134(41):2073-6. PubMed ID: 19802769
    [No Abstract]   [Full Text] [Related]  

  • 44. [Ascitic cirrhosis. Its treatment with testosterone].
    MAGGI AL; MEEROFF M; COHEN J
    Rev Med Chil; 1961 Oct; 89():840-3. PubMed ID: 14468267
    [No Abstract]   [Full Text] [Related]  

  • 45. [Ascitic cirrhosis. Its treatment with testosterone].
    MAGGI AL; MEEROFF M; COHEN J
    Dia Med; 1961 Apr; 33():506-10. PubMed ID: 13765208
    [No Abstract]   [Full Text] [Related]  

  • 46. [Peritoneojugular shunt in question].
    Kammerer J; Vernisse B; Fouet P
    Gastroenterol Clin Biol; 1980 May; 4(5):387-8. PubMed ID: 7399208
    [No Abstract]   [Full Text] [Related]  

  • 47. [The development of FSCLZLY--an ascites-ultrafiltration instrument].
    Liu CY; Hu DR; Peng XJ; Tian HY; Gong LJ; Chen TB
    Zhongguo Yi Liao Qi Xie Za Zhi; 2002 Mar; 26(2):131-2, 143. PubMed ID: 16104180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Creation of a transjugular intrahepatic portosystemic shunt with use of a preexisting portal-hepatic vein fistula as an alternative route.
    Hagspiel KD; Shih MC; Kanu J; Caldwell SH; Angle JF
    J Vasc Interv Radiol; 2005 Mar; 16(3):426-8. PubMed ID: 15758145
    [No Abstract]   [Full Text] [Related]  

  • 49. Sleep apnea obstructive syndrome: a new complication previously undescribed in cirrhotic patients with ascites.
    Crespo J; Cifrián J; Pinto JA; Jiménez-Gómez A; Pons-Romero F
    Am J Gastroenterol; 2003 Dec; 98(12):2815-6. PubMed ID: 14687850
    [No Abstract]   [Full Text] [Related]  

  • 50. Hydrothorax without ascites in liver cirrhosis.
    Pop CM; Gherasim RM; Dumitraşcu DL
    Rom J Gastroenterol; 2003 Dec; 12(4):315-7. PubMed ID: 14726978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Care and management of the patient with ascites.
    Lee L; Grap MJ
    Medsurg Nurs; 2008 Dec; 17(6):376-81; quiz 382. PubMed ID: 19248401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trial of hydrochlorothiazide in ascites of bilharzial hepatolienal fibrosis.
    EL-EBRASHY N
    J Egypt Med Assoc; 1962; 45():430-9. PubMed ID: 13889773
    [No Abstract]   [Full Text] [Related]  

  • 53. [New views on the origin and therapy of ascites in liver cirrhosis].
    CANELLA C
    Minerva Med; 1957 Nov; 48(90):3747-52. PubMed ID: 13503859
    [No Abstract]   [Full Text] [Related]  

  • 54. [Protein deficiency in pathogenesis of ascites in liver cirrhosis].
    CANELLA C
    Arcisp S Anna Ferrara; 1954; 7(1):7-27. PubMed ID: 13198660
    [No Abstract]   [Full Text] [Related]  

  • 55. [A multilevel method of treatment of ascites with liver cirrhosis].
    Pirtskhalava TL; Granov DA
    Vestn Khir Im I I Grek; 2003; 162(5):36-9. PubMed ID: 14768101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Low salt concentrated human albumin in therapy of ascites due to liver cirrhosis].
    SCHOUTEN J
    Ned Tijdschr Geneeskd; 1953 Nov; 97(45):2919-25. PubMed ID: 13144807
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
    Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
    Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mechanisms of the formation of ascites in patients with cirrhosis of the liver. II. General factors].
    RIVERA A; DIES F
    Rev Invest Clin; 1961; 13():157-90. PubMed ID: 14038706
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the pathogenesis of ascites and hepatic coma after paracentesis in cirrhosis of the liver].
    ZANNINI L
    Minerva Med; 1961 Oct; 52():3487-92. PubMed ID: 14009820
    [No Abstract]   [Full Text] [Related]  

  • 60. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
    Albillos A; Bañares R; González M; Catalina MV; Molinero LM
    J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.